Beech.

Xylooligosaccharides sold as prebiotics are made by hydrolysing xylan from beech wood. Bifidobacteria are among the few gut genera equipped to break the xylose backbone down, so the pairing is substrate plus the organism that can use it. This is a fermentation-substrate relationship, not evidence of a clinical outcome.

Beechwood xylooligosaccharides are xylose based and ferment fast in the proximal colon. Inulin is fructose based and ferments further along. Formulators combine them to spread fermentation rather than to concentrate it in one segment. The rationale is structural, and gas tolerance still varies by person.

Fermentation of beechwood xylooligosaccharides yields acetate and lactate, which butyrate producing species take up in a cross feeding step. Adding butyrate directly and adding the substrate that generates it are two different routes to the same short chain fatty acid. Measured shifts in stool short chain fatty acids are markers, not outcomes.

Beechwood derived oligosaccharides are used as the carbohydrate half of synbiotic formulas. The organism supplies the enzymes, the xylan fragment supplies the fuel. Whether a given strain actually uses xylose chains depends on the strain, so the pairing has to be matched rather than assumed.

Xylitol refined from beech xylan is non fermentable by oral streptococci, and calcium salts are added to chewables for remineralisation chemistry. The pairing is a formulation convention in oral care products. It says nothing about systemic absorption of either component.

Xylitol from beech wood is absorbed slowly and pulls water into the lumen. Magnesium oxide and citrate do the same. Stacking both can bring on loose stools at intakes where either alone might be tolerated. Worth flagging on a label rather than hiding.